The SLE associate TT>A risk alleles, through their inability to effectively deliver NF-κB to the TNFAIP3 promoter, impair A20 expression leading to enhanced NF-κB pathway activity and predisposition to autoimmune disease. This evidence concerns the gene TNFAIP3 and systemic lupus erythematosus.